Business
International Flavors & Fragrances develops flavors, fragrances, food ingredients, enzymes and bioscience solutions.
IFF's revenue contraction produced a loss, but positive free cash flow and portfolio simplification preserved liquidity while the ingredients group reset its segments.
The read at a glance✓ Audited against SEC data
- Growth — Revenue declined 5.2%Watch
- Profitability — The company moved from net income of $267M to a net loss of $359MWatch
- Cash flow — Free cash flow declined 57.8% to $256M from $607MWatch
- Margins — Operating margin contracted 1018 bps to -3.51%Watch
- Accounting — Loss-making year with positive cash flowWatch
- Insiders — 11 purchases and 4 salesOK
Where the revenue comes from
Fiscal 2025, as INTERNATIONAL FLAVORS & FRAGRANCES INC reports it. History and quarterly detail are in the app.
- Food Ingredients$3.3B
- Taste$2.5B
- Scent$2.5B
- Health & Biosciences$2.3B
- Pharma Solutions$369.0M
Leadership changes
From INTERNATIONAL FLAVORS & FRAGRANCES INC's own filings, the day they're filed.
- Richard Mulligan · Director · appointmenteff. 2025-10-20
- Paul Fribourg · directors · appointmenteff. 2025-07-29
- Virginia Drosos · directors · appointmenteff. 2025-06-16
Latest filings
- 8-K · Company announcement2026-08-04
- 8-K · Company announcement2026-08-04
- 10-Q · Quarterly report2026-08-04
- 8-K · Company announcement2026-06-23
- 8-K · Company announcement2026-06-01
In the full recordFree for 14 days
- What changed🔒
- Insider signal🔒
- Growth quality🔒
- Margins & accounting🔒
- Capital allocation🔒
- Real risks🔒
- The long arc🔒
- Company history🔒
- The filings, readable — with what changed vs the prior year highlighted🔒
- Full financial statements, industry-aware, sources cited throughout🔒
- Forensic score history & components — the trend, not one year🔒
- Ownership: insider buys/sells, clusters, activist stakes🔒
- Ana — ask about INTERNATIONAL FLAVORS & FRAGRANCES INC, every answer cited to the official filings🔒
Every figure comes from the company's filings, and analysis whose figures don't match SEC data is rejected before publication.
14-day free trial, no credit card. For research purposes only; not investment advice.